Hospital Universitari Vall d'Hebron
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona, Spain9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL | indolent B-cell non-Hodgkin lymphoma | Recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT03571568 | |
| GETNE Registration of Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Not stated | 2026-09-22 | NCT03765333 | |
| Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain Metastasis | Brain Metastases, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-09 | NCT06315010 | |
| Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC | Resectable Hepatocellular Carcinoma | Recruiting | Phase 2 | 2026-07-08 | NCT07018947 | |
| Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Inflammation, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, agranulocytosis, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukocyte disorder, leukopenia, neoplasm, neutropenia, toxic shock syndrome | Recruiting | Not stated | 2026-06-15 | NCT07277387 | |
| Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma | pancreatic adenocarcinoma | Recruiting | Phase 1 | 2026-04-30 | NCT06892054 | |
| Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-11-25 | NCT05547321 | |
| Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery. | Digestive System Diseases, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, biliary tract disorder, cholecystolithiasis, cholelithiasis, gallbladder disorder, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2025-05-20 | NCT04735198 | |
| The Impact of Radiotherapy on Oligometastatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder | Recruiting | Not stated | 2024-11-18 | NCT05933876 |